rs8177877
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004483.5(GCSH):c.218A>G(p.Asn73Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00813 in 1,600,706 control chromosomes in the GnomAD database, including 513 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.035 ( 248 hom., cov: 32)
Exomes 𝑓: 0.0053 ( 265 hom. )
Consequence
GCSH
NM_004483.5 missense
NM_004483.5 missense
Scores
4
14
Clinical Significance
Conservation
PhyloP100: 4.12
Publications
9 publications found
Genes affected
GCSH (HGNC:4208): (glycine cleavage system protein H) Degradation of glycine is brought about by the glycine cleavage system, which is composed of four mitochondrial protein components: P protein (a pyridoxal phosphate-dependent glycine decarboxylase), H protein (a lipoic acid-containing protein), T protein (a tetrahydrofolate-requiring enzyme), and L protein (a lipoamide dehydrogenase). The protein encoded by this gene is the H protein, which transfers the methylamine group of glycine from the P protein to the T protein. Defects in this gene are a cause of nonketotic hyperglycinemia (NKH). Two transcript variants, one protein-coding and the other probably not protein-coding,have been found for this gene. Also, several transcribed and non-transcribed pseudogenes of this gene exist throughout the genome.[provided by RefSeq, Jan 2010]
GCSH Gene-Disease associations (from GenCC):
- glycine encephalopathyInheritance: AR Classification: STRONG, LIMITED Submitted by: ClinGen, Ambry Genetics
- multiple mitochondrial dysfunctions syndrome 7Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- infantile glycine encephalopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- neonatal glycine encephalopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- atypical glycine encephalopathyInheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.003116995).
BP6
Variant 16-81090611-T-C is Benign according to our data. Variant chr16-81090611-T-C is described in ClinVar as Benign. ClinVar VariationId is 462901.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.111 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GCSH | ENST00000315467.9 | c.218A>G | p.Asn73Ser | missense_variant | Exon 2 of 5 | 1 | NM_004483.5 | ENSP00000319531.3 | ||
| ENSG00000284512 | ENST00000640345.1 | c.218A>G | p.Asn73Ser | missense_variant | Exon 2 of 6 | 5 | ENSP00000492798.1 | |||
| ENSG00000260643 | ENST00000564536.2 | c.218A>G | p.Asn73Ser | missense_variant | Exon 2 of 6 | 5 | ENSP00000491651.1 |
Frequencies
GnomAD3 genomes AF: 0.0347 AC: 5280AN: 152080Hom.: 247 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
5280
AN:
152080
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0117 AC: 2947AN: 251428 AF XY: 0.00951 show subpopulations
GnomAD2 exomes
AF:
AC:
2947
AN:
251428
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00532 AC: 7713AN: 1448508Hom.: 265 Cov.: 28 AF XY: 0.00496 AC XY: 3577AN XY: 721616 show subpopulations
GnomAD4 exome
AF:
AC:
7713
AN:
1448508
Hom.:
Cov.:
28
AF XY:
AC XY:
3577
AN XY:
721616
show subpopulations
African (AFR)
AF:
AC:
3794
AN:
33174
American (AMR)
AF:
AC:
356
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
AC:
852
AN:
26052
East Asian (EAS)
AF:
AC:
628
AN:
39626
South Asian (SAS)
AF:
AC:
215
AN:
85962
European-Finnish (FIN)
AF:
AC:
6
AN:
53412
Middle Eastern (MID)
AF:
AC:
115
AN:
5404
European-Non Finnish (NFE)
AF:
AC:
1001
AN:
1100278
Other (OTH)
AF:
AC:
746
AN:
59892
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
368
736
1105
1473
1841
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
154
308
462
616
770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0348 AC: 5298AN: 152198Hom.: 248 Cov.: 32 AF XY: 0.0336 AC XY: 2499AN XY: 74422 show subpopulations
GnomAD4 genome
AF:
AC:
5298
AN:
152198
Hom.:
Cov.:
32
AF XY:
AC XY:
2499
AN XY:
74422
show subpopulations
African (AFR)
AF:
AC:
4726
AN:
41504
American (AMR)
AF:
AC:
193
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
121
AN:
3472
East Asian (EAS)
AF:
AC:
74
AN:
5180
South Asian (SAS)
AF:
AC:
21
AN:
4822
European-Finnish (FIN)
AF:
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
AC:
98
AN:
68020
Other (OTH)
AF:
AC:
56
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
247
494
741
988
1235
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
3
ESP6500AA
AF:
AC:
469
ESP6500EA
AF:
AC:
32
ExAC
AF:
AC:
1658
Asia WGS
AF:
AC:
58
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Glycine encephalopathy Benign:1
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;.;L;.
PhyloP100
PrimateAI
Benign
T
PROVEAN
Uncertain
.;.;.;D;.
REVEL
Benign
Sift
Benign
.;.;.;T;.
Sift4G
Benign
.;.;.;T;.
Polyphen
0.0040
.;.;.;B;.
Vest4
0.082
MPC
0.32
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.